Insight Molecular Diagnostics Inc. · NASDAQ:IMDX
BROADWOOD PARTNERS, L.P. reported a 40.20% stake in Insight Molecular Diagnostics Inc. (Schedule 13D/A)
Event Feb 6, 2025 · Filed Feb 10, 2025
BROADWOOD PARTNERS, L.P. reported a 40.20% stake in Insight Molecular Diagnostics Inc., 11,560,193 shares, with active intent on Feb 6, 2025. Filed Feb 10, 2025 (Schedule 13D/A).
- Stake
- 40.20%
- Shares
- 11,560,193
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BROADWOOD PARTNERS, L.P. | 40.20% | 11,560,193 |
| BROADWOOD CAPITAL INC. | 40.20% | 11,560,193 |
| NEAL C. BRADSHER | 40.20% | 11,560,350 |
Source
Related
- Insight Molecular Diagnostics Inc.
- Broadwood Partners, L.P.
- Insight Molecular Diagnostics Inc. shareholders
- Schedule 13D/A · Broadwood Partners, L.P. · Apr 27, 2026
- Schedule 13D/A · Broadwood Partners, L.P. · Feb 12, 2026
- Form 4 · Silverman Lou · Jul 6, 2026
- Form 4 · Last Andrew J. · Jul 6, 2026
- Form 4 · Arno Andrew · Jul 6, 2026
- Form 4 · Silverman Lou · Jun 15, 2026
- Form 4 · Last Andrew J. · Jun 15, 2026